Chemi-Verse™ PAK2 Kinase Assay Kit

Catalog #
82221
$575 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The Chemi-Verse™ PAK2 Kinase Assay Kit is designed to measure PAK2 (P21 protein (Cdc42/Rac)-activated kinase 2) serine/threonine kinase activity for screening and profiling applications using ADP-Gloas a detection reagent. The assay kit comes in a convenient 96-well format, with enough purified recombinant PAK2 kinase, kinase substrate, ATP, and kinase assay buffer for 100 enzyme reactions.

Synonyms
Gamma-PAK, PAK65, S6/H4 kinase, p21-activated kinase 2 (PAK-2), p58, Serine/threonine-protein kinase PAK 2
Product Info
Storage and Usage
Citations
Assay Kit Format
Luminescent
Materials Required But Not Supplied
  • ADP-Glo™ Kinase Assay (Promega #V6930)
  • DTT (Dithiothreitol), 1M, optional
  • Microplate reader capable of reading luminescence
  • Adjustable micropipettor and sterile tips
  • 30°C incubator
Format
Catalog # Name Amount Storage
  PAK2* 5 µg -80°C
79334 5x Kinase Buffer 1 1.5 ml -20°C
79686 500 µM ATP 50 µl -20°C
  PAKtide, 1 mg/ml 500 µl -20°C
79696 White 96-well plate 1 Room Temp

*The concentration of the protein is lot-specific and will be indicated on the tube.

UniProt #
Q13177
Background

PAK2, also known as P21 protein (Cdc42/Rac)-activated kinase 2, belongs to the group I of the PAK family of serine/threonine kinases. PAK2 can be found both in the cytosol and nucleus of most cells. It can be activated by cellular context dependent partners, and plays a role in several crucial cellular processes, such as cell proliferation and growth. PAK2, in particular, is linked to responses to caspase-mediated apoptosis. The molecule is cleaved in response to cell stress in a caspase-dependent manner, but its non-cleaved form seems to have anti-apoptotic effects. Amongst the PAK proteins, it is the most common protein mutated in cancer, particularly common in lung cancer. Once activated it can modulate the activity of proteins like c-Jun to stimulate melanoma cell growth, or caspase-7 to inhibit apoptosis in breast cancer cells.  Inhibition of PAK2 activity or expression has shown promising results in research studies and may represent a new therapeutic approach in cancer therapy.

References

Grebenova D., et al., 2019 Scientific Reports 9: 17171.